Diclofenac Potassium

Contusions, Pain, Photophobia + 54 more
Treatment
10 FDA approvals
20 Active Studies for Diclofenac Potassium

What is Diclofenac Potassium

DiclofenacThe Generic name of this drug
Treatment SummaryDiclofenac is a type of anti-inflammatory medication used to reduce pain and inflammation caused by a variety of conditions. It works by blocking enzymes that produce hormones that cause inflammation and pain. It is often used as a first-line treatment for acute and chronic pain, and is sometimes taken in combination with another drug to prevent stomach ulcers. Diclofenac was first approved by the FDA in 1988 and is sold under the brand name Voltaren.
Voltarenis the brand name
image of different drug pills on a surface
Diclofenac Potassium Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Voltaren
Diclofenac
1988
767

Approved as Treatment by the FDA

Diclofenac, also called Voltaren, is approved by the FDA for 10 uses including Osteoarthritis of the Knee and Pain .
Osteoarthritis of the Knee
Used to treat Osteoarthritis of the Knee in combination with Capsaicin
Pain
Helps manage Pain
Postoperative Inflammatory Response
Chronic Pain
Helps manage Pain
Osteoarthritis (OA)
Used to treat Osteoarthritis (OA) in combination with Misoprostol
Stomach Ulcer
Used to treat develop NSAID-induced gastric ulcers in combination with Misoprostol
Osteoarthritis of the Knee
Used to treat Osteoarthritis of the Knee in combination with Capsaicin
Osteoarthritis
Used to treat Osteoarthritis (OA) in combination with Misoprostol
Rheumatoid Arthritis
Cataract Surgery

Effectiveness

How Diclofenac Potassium Affects PatientsDiclofenac is used to reduce pain, inflammation, and fever. However, it can also increase the chances of developing a stomach ulcer because it reduces the amount of protective mucus in the stomach.
How Diclofenac Potassium works in the bodyDiclofenac works by blocking the enzymes responsible for producing prostaglandin molecules. These molecules are responsible for pain and inflammation, so when they are blocked, the pain and inflammation is reduced. Diclofenac also reduces sensitivity to heat and other stimuli, as well as preventing white blood cells from flowing to sites of inflammation. It also reduces the activity of NF-Kappa B, a contributor to cancer, and stops tumor suppressor proteins from leaving the cell. Finally, it stops the activity of neurons in the hypothalamus that create a fever. All of these effects work together to reduce pain and inflammation caused

When to interrupt dosage

The suggested measure of Diclofenac Potassium is contingent upon the determined circumstance, such as Joint Pain, Postoperative Inflammatory Response and Osteoarthritis (OA). The volume of dosage can be found in the table presented below, depending on the mode of administration (e.g. Cream; Kit; Solution or Kit; Oil; Solution / drops).
Condition
Dosage
Administration
Pain
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Arthritis, Gouty
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Arthralgia
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Postoperative Inflammatory Response
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Pain
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Contusions
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Photophobia
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Pain
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Fever
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Postoperative
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Postoperative Pain
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Conjunctivitis
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Radiculopathy
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Pain
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Osteoarthritis of the Knee
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Wounds, Nonpenetrating
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Arthritis, Gouty
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Ankylosing Spondylitis
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Inflammation
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual
Acute Coryza
100.0 mg, , 1.0 mg/mL, 50.0 mg, 75.0 mg, 16.05 mg/mL, 3.5 mg/mL, 25.0 mg, 0.01 mg/mg, 180.0 mg, 0.018 mg/mg, 1.0 mg/mg, 0.1 %, 1.5 %, 30.0 mg/mL, 0.03 mg/mg, 2.32 %, 1.16 %, 37.5 mg/mL, 0.02 mg/mg, 18.0 mg, 35.0 mg, 0.3 mg/mg, 10.0 mg, 1000.0 mg, 10.0 mg/mL, 12.5 mg, 0.015 mg/mg, 100.0 mg/mL, 3.0 mg/mg, 5.7 mg/mg, 13.0 mg, 0.013 mg, 0.001 mg/mg
, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Oral, Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Tablet, delayed release - Oral, Tablet, Tablet - Oral, Powder, for solution - Oral, Powder, for solution, Solution / drops - Ophthalmic, Solution / drops, Tablet, delayed release, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Topical, Gel, Gel - Topical, Tablet, extended release, Tablet, extended release - Oral, Patch, Patch - Topical, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Ophthalmic, Suppository, Rectal, Suppository - Rectal, Kit, Aerosol, metered, Aerosol, metered - Topical, Kit - Topical, Tablet, sugar coated - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule - Oral, Capsule, Cream, Cream - Topical, Powder - Oral, Transdermal, Solution / drops - Transdermal, Tablet, sugar coated, Oral; Topical, Kit - Oral; Topical, Tablet, coated, Tablet, coated - Oral, Drug delivery system - Topical, Drug delivery system, Sublingual

Warnings

Diclofenac Potassium Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Heart failure
Do Not Combine
Crohn's Disease
Do Not Combine
recent history of anal bleeding
Do Not Combine
Hemorrhagic Disorders
Do Not Combine
Gastritis
Do Not Combine
inflammatory lesions of the Rectum
Do Not Combine
active Gastrointestinal Bleeding
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
active Gastrointestinal Perforation
Do Not Combine
Duodenal Ulcer
Do Not Combine
Coronary Artery Bypass Grafting
Do Not Combine
Severe Hepatic Impairment
Do Not Combine
Ulcerative Colitis
Do Not Combine
Liver Diseases
Do Not Combine
Stroke
Do Not Combine
Third trimester of pregnancy
Do Not Combine
Hematochezia
Do Not Combine
Kidney Failure
Do Not Combine
Kidney Failure
Do Not Combine
Anus
Do Not Combine
Ulcer
Do Not Combine
damaged skin
Do Not Combine
Gastric ulcer
Do Not Combine
Peptic Ulcer
Do Not Combine
Hyperkalemia
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Diclofenac may interact with Pulse Frequency
There are 20 known major drug interactions with Diclofenac Potassium.
Common Diclofenac Potassium Drug Interactions
Drug Name
Risk Level
Description
Brigatinib
Major
The metabolism of Brigatinib can be decreased when combined with Diclofenac.
Cabazitaxel
Major
The metabolism of Cabazitaxel can be decreased when combined with Diclofenac.
Cyclophosphamide
Major
The metabolism of Cyclophosphamide can be decreased when combined with Diclofenac.
Enasidenib
Major
The metabolism of Enasidenib can be decreased when combined with Diclofenac.
Erlotinib
Major
The metabolism of Erlotinib can be decreased when combined with Diclofenac.
Diclofenac Potassium Toxicity & Overdose RiskOverdosing on Voltaren can lead to symptoms such as fatigue, nausea, vomiting, upper abdominal pain, and bleeding from the digestive tract. In rare cases, patients may experience high blood pressure, kidney damage or failure, hypoventilation, or coma. Treatments for Voltaren overdose include inducing vomiting and activated charcoal, as long as the overdose occurred within the last 4 hours.
image of a doctor in a lab doing drug, clinical research

Diclofenac Potassium Novel Uses: Which Conditions Have a Clinical Trial Featuring Diclofenac Potassium?

Currently, 491 active clinical trials are assessing the capacity of Diclofenac Potassium to mitigate Inflammation, enhance Argon Laser Trabeculoplasty and assuage Osteoarthritis of the Knee.
Condition
Clinical Trials
Trial Phases
Osteoarthritis of the Knee
84 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 3, Phase 4, Early Phase 1
Inflammation
57 Actively Recruiting
Not Applicable, Early Phase 1, Phase 1, Phase 2, Phase 3, Phase 4
Chronic Pain
128 Actively Recruiting
Not Applicable, Phase 2, Phase 4, Phase 3, Early Phase 1, Phase 1
Rheumatoid Arthritis
56 Actively Recruiting
Not Applicable, Phase 4, Phase 3, Phase 2, Phase 1
Postoperative Pain
19 Actively Recruiting
Phase 4, Phase 2, Phase 1, Phase 3, Not Applicable
Dysmenorrhea
1 Actively Recruiting
Not Applicable
Muscle Pain
3 Actively Recruiting
Phase 4, Not Applicable, Phase 2
Conjunctivitis
0 Actively Recruiting
Musculoskeletal System
1 Actively Recruiting
Not Applicable
corneal refractive surgery
0 Actively Recruiting
Postoperative Inflammatory Response
0 Actively Recruiting
Photophobia
2 Actively Recruiting
Not Applicable
Pain
3 Actively Recruiting
Not Applicable
Stomach Ulcer
0 Actively Recruiting
Rheumatism
0 Actively Recruiting
Juvenile arthritis
8 Actively Recruiting
Phase 2, Not Applicable, Phase 3
radial keratotomy
0 Actively Recruiting
Joints
0 Actively Recruiting
Pericarditis
1 Actively Recruiting
Phase 2, Phase 3
Acute Coryza
0 Actively Recruiting

Diclofenac Potassium Reviews: What are patients saying about Diclofenac Potassium?

5Patient Review
3/19/2014
Diclofenac Potassium for Rheumatic Disease causing Pain & Stiffness in Backbone
I was able to get back to my normal routine within just a few days of starting this medication. Not only that, but it didn't bother my stomach like other medications have in the past.
5Patient Review
7/17/2014
Diclofenac Potassium for Pain
This medicine was really effective in treating my lower back pain. I would have continued to take it if it weren't for the fact that it's an NSAID, and I can't take those anymore because of stomach problems.
5Patient Review
5/27/2014
Diclofenac Potassium for Pain
This medication was a godsend after I broke two ribs. It allowed me to function normally while it was working, and the pain was unbearable when it began to wear off.
5Patient Review
12/25/2015
Diclofenac Potassium for Gout
I was experiencing pain in my left heel and took ibuprofen 400mg and allopurinol 100mg for more than two weeks without any relief. I started taking diclofenac potassium oral 100mg and parastaimal 500mg daily, and within two days the pain was gone.
5Patient Review
9/9/2015
Diclofenac Potassium for Pain
This medication was a godsend for my chronic pain. I felt great within a few days and was able to move around without stiffness or pain. However, now that I'm out of my prescription, the pain has come back full force and I am miserable once again.
5Patient Review
8/29/2015
Diclofenac Potassium for Inflammation of the Sac Surrounding the Joint - Bursitis
The pain relief I experienced from this medication was nothing short of miraculous.
5Patient Review
5/24/2021
Diclofenac Potassium for Migraine Headache
This medication is a great rescue for migraines. It takes away about 75% of the pain, which makes it much easier to get through the day. I also haven't had any problems with taking it on an empty stomach.
5Patient Review
1/12/2016
Diclofenac Potassium for Rheumatoid Arthritis
I'm so glad I found this drug! It's been a huge help. However, I still need to take my norco.
5Patient Review
9/19/2016
Diclofenac Potassium for Severe Lower Back Pain from Kidney Stones
This provided immediate relief, which was great.
5Patient Review
5/26/2019
Diclofenac Potassium for Rheumatoid Arthritis
I really appreciate this medication. It's helped me a lot.
5Patient Review
7/4/2014
Diclofenac Potassium for Painful Periods
This medication was very effective in managing my pain during menstruation.
4.3Patient Review
3/31/2014
Diclofenac Potassium for Inflammation of the Tendon
This treatment helped with my muscle pain.
3.3Patient Review
2/3/2014
Diclofenac Potassium for Inflammation of the Tendon
The IT Band is a common source of pain for many people.
3Patient Review
9/10/2017
Diclofenac Potassium for Migraine Headache
It's really tough on my stomach, and the cost is outrageous.
2.7Patient Review
7/11/2014
Diclofenac Potassium for Inflammation of the Sac Surrounding the Joint - Bursitis
I've gone from being really cold (shivering, cold hands and feet) to being excessively hot over the entire portion of my body. Its fore an inflamed tail bone which turned red and feels like a bruise someone his constantly touching.
2Patient Review
8/15/2014
Diclofenac Potassium for Rheumatoid Arthritis
I was hospitalized after taking just five pills of this medication. I couldn't respond to the doctor's questions. He said that this medicine caused me a lot of harm and pain. I'm still suffering and now have to use a walker, which is something new for me.
2Patient Review
1/4/2015
Diclofenac Potassium for Joint Damage causing Pain and Loss of Function
I took this medication for approximately six weeks to treat inflammation in my shoulder joints. Unfortunately, the side effects were really terrible - I was constantly moody and got my period all the time. I would not recommend this medication for women of child-bearing age. My doctor didn't mention any of these potential side effects, so I had to figure it out on my own!
1.7Patient Review
6/30/2016
Diclofenac Potassium for Pain
I have fibro, RA, and migraines. They took my old medication away and replaced it with this one. I feel like I'm constantly hungover and all I want to do is sleep. When I called my doctor about it, they said it wasn't the medication. Hello? If it's not the medication, then what is it? Ginger tea isn't cutting it.
1.7Patient Review
9/13/2017
Diclofenac Potassium for Pain
I was given this medication for lower back pain, but I am now experiencing stomach pain. This is not an ideal situation, so I will have to speak with my doctor about finding a different treatment option.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about diclofenac potassium

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is diclofenac a strong painkiller?

"Diclofenac is stronger than ibuprofen and should be taken every six to eight hours. Ibuprofen usually needs to be taken in high doses to relieve pain associated with arthritis."

Answered by AI

What is diclofenac potassium used for?

"This medication is known as a nonsteroidal anti-inflammatory drug (NSAID).

This medication is used to relieve various kinds of pain and swelling, including muscle aches, backaches, dental pain, menstrual cramps, and sports injuries. It also helps reduce pain, swelling, and stiffness caused by arthritis."

Answered by AI

What are the dangers of taking diclofenac?

"NSAIDs such as diclofenac can cause painful ulcers, bleeding, or holes in the stomach or intestine. These problems can develop at any time during treatment and sometimes without any warning symptoms. In rare cases, they can even be fatal."

Answered by AI

Is diclofenac potassium a painkiller?

"If you need to take an NSAID for a long period of time, your doctor or pharmacist may recommend ibuprofen or naproxen instead of diclofenac. This is because diclofenac is more likely to cause heart problems."

Answered by AI

Clinical Trials for Diclofenac Potassium

Have you considered Diclofenac Potassium clinical trials? We made a collection of clinical trials featuring Diclofenac Potassium, we think they might fit your search criteria.Go to Trials
Image of Sunnybrook Health Sciences Centre in Toronto, Canada.

Steroids for Rheumatoid Arthritis

18+
All Sexes
Toronto, Canada
People living with rheumatoid arthritis (RA) often experience flares-periods where their symptoms suddenly get worse. These flares can cause significant pain, make it harder to move and do daily activities, and lower overall quality of life. Doctors often treat flares with medications called glucocorticoids (GCs), which reduce inflammation. These medications can be taken by mouth (oral/PO) or given as a single injection into the muscle (intramuscular/IM). However, it's not clear which option works better from the patient's point of view-especially when it comes to relief of symptoms, improvements in function, and satisfaction with treatment. Most research so far has focused on how well the drugs control the disease, rather than how they impact the patient's overall experience. Research Questions: 1. Does a single GC injection work just as well as taking pills over a few weeks in improving symptoms reported by patients? 2. How do the two treatments compare in terms of symptom relief, ability to function, and patient satisfaction? 3. What do patients think and feel about using GCs to treat RA flares? What the Investigators Think: The investigators believe that a one-time GC injection is just as good as taking pills for a few weeks when it comes to managing RA flares. In fact, the injection might even be safer and preferred by patients. What the Investigators are Doing: The investigators will study 220 adults with RA who are currently having a flare (with at least 3 swollen and tender joints). These patients will be recruited from rheumatology clinics at the University of Toronto and must not have used GCs in the past month. They will be randomly assigned to receive either: A single injection (Methylprednisolone 120 mg), or Oral pills (Prednisone starting at 15 mg daily and tapering down over 3 weeks). The main thing the investigators will look at is how much better patients feel after 6 weeks, based on a questionnaire designed to measure RA flares. The investigators will also look at how well they function, how satisfied they are with the treatment, and whether they had any side effects. In addition, 20 patients (10 from each group) will be interviewed to understand their experiences and opinions about flare treatment in more detail. Why This Is Possible: The investigators have already surveyed University of Toronto rheumatologists who support the idea and provided input on study design. The investigators have also partnered with experts in research methods, national arthritis organizations, and patient groups to make sure the study is relevant and meaningful. Ethics approval has been obtained. Why It Matters: RA flares can have a major impact on people's lives. While current treatments help control inflammation, the investigators need to better understand how these treatments affect people from their own perspective. This study will shift the focus to what matters most to patients, helping doctors and patients choose the best treatment based not only on medical results but also on the patient's experience. This could lead to more effective and personalized care for people living with RA.
Phase 4
Waitlist Available
Sunnybrook Health Sciences Centre (+4 Sites)
Image of California Clinical Trials Medical Group in Glendale, United States.

NTR-1011 for Lupus and Rheumatoid Arthritis

18 - 75
All Sexes
Glendale, CA
This phase 1a and 1b study is designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary efficacy of NTR-1011 in healthy adults and in adult patients with systemic lupus erythematosus and rheumatoid arthritis. The main goals of this study are to determine the safety profile of NTR-1011 across subcutaneous and intravenous dose levels, understand how the drug behaves in the body, characterize its biological activity through relevant pharmacodynamic markers, assess the potential for immune responses to treatment, and explore early signals of clinical benefit in autoimmune disease settings. This is a randomized, double blind, placebo controlled study that begins with a single ascending dose evaluation in healthy volunteers followed by a multiple dose assessment in patients. The design is intended to define the highest safe and well tolerated dose, establish a robust PK and PD baseline, and generate initial patient level evidence to support dose selection and advancement into subsequent clinical development.
Phase 1
Recruiting
California Clinical Trials Medical GroupHakop Gevorkyan, MDNeutrolis
Have you considered Diclofenac Potassium clinical trials? We made a collection of clinical trials featuring Diclofenac Potassium, we think they might fit your search criteria.Go to Trials
Image of Vanderbilt University Medical Center in Nashville, United States.

Lidocaine Infusions for Postoperative Pain

18+
All Sexes
Nashville, TN
The goal of this single-center, pragmatic, randomized, blinded, placebo-controlled trial is to evaluate the impact of intravenous (IV) lidocaine within the existing Enhanced Recovery After Surgery (ERAS)program on outcomes in patients after major abdominal surgery. The main questions the trial aims to answer are: The primary hypothesis is that utilization of IV lidocaine as part of a perioperative multimodal pain regimen will result in a reduction in hospital Case Mix Index-Adjusted Resource Length of Stay (CARLOS). The secondary hypotheses are that lidocaine infusion will result in a reduction in total inpatient opioid consumption (oral morphine milligram equivalents, oMMEs) and pain scores, and improved surgical outcomes (including return of bowel function, ileus, nausea, rapid responses called, surgical site infections, and ICU transfers), while also having minimal incidence of side effects (including double/blurry vision, tinnitus, sedation, and adverse events requiring early cessation).
Phase 4
Waitlist Available
Vanderbilt University Medical CenterDanial Shams, MD
Have you considered Diclofenac Potassium clinical trials? We made a collection of clinical trials featuring Diclofenac Potassium, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security